日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A human pathophysiological 3D-bone marrow model reveals immune and stromal cell heterogeneity.

人类病理生理学 3D 骨髓模型揭示了免疫细胞和基质细胞的异质性。

Giannini Mariette, Campione Giulia, Torcq Lea, Donadelli Sylvain, Bencheikh Maroua, Bounaud Sophia, Jeanpierre Sandrine, Geistlich Kevin, Maguer-Satta Veronique, Lefort Sylvain, Leca Julie

Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease

镰状细胞病患儿及成人患者急症和危重症管理指南

Mekontso Dessap, Armand; Dauger, Stephane; Khellaf, Mehdi; Agbakou, Maite; Agut, Sophie; Angoulvant, François; Arlet, Jean-Benoît; Aubron, Cécile; Baudin, Florent; Boissier, Florence; Bounaud, Nicolas; Catoire, Pierre; Cecchini, Jérôme; Chaiba, Djamila; Chauvin, Anthony; Chocron, Richard; Douay, Benedicte; Douillet, Delphine; Elenga, Narcisse; Flechelle, Olivier; Gendreau, Ségolène; Goddet, Sybille; Guenezan, Jeremy; Habibi, Anoosha; Heilbronner, Claire; Koehl, Bérengère; Le Borgne, Pierrick; Le Conte, Philippe; Legras, Annick; Levy, Michael; Maitre, Bernard; Oberlin, Mathieu; Oualha, Mehdi; Peschanski, Nicolas; Pirenne, France; Pondarre, Corinne; Rambaud, Jérôme; Razazi, Keyvan; Rousseau, Geoffroy; Schirmann, Aurélie; Thuret, Isabelle; Valentino, Ruddy; Voiriot, Guillaume; Villoing, Barbara; Grimaud, Marion; Jean, Sandrine

SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

SGX523 是一种选择性极好的 ATP 竞争性 MET 受体酪氨酸激酶抑制剂,具有体内抗肿瘤活性

Sean G Buchanan, Jorg Hendle, Patrick S Lee, Christopher R Smith, Pierre-Yves Bounaud, Katti A Jessen, Crystal M Tang, Nanni H Huser, Jeremy D Felce, Karen J Froning, Marshall C Peterman, Brandon E Aubol, Steve F Gessert, J Michael Sauder, Kenneth D Schwinn, Marijane Russell, Isabelle A Rooney, Jaso